文献速递头颈PET

一种新型黑色素靶向18F-PFPN正电子发射断层成像用于诊断眼及眶部黑色素瘤

A Novel Melanin-Targeted 18F-PFPN Positron Emission Tomography Imaging for Diagnosing Ocular and Orbital Melanoma.
PubMed 文献 · Korean J Radiol · 2024-07-10

回顾性分析3例病理确诊的眼或眶部黑色素瘤患者,均行18F-PFPN与18F-FDG PET。18F-PFPN检出全部3个原发肿瘤,18F-FDG仅检出2个;病灶SUVmax为18F-FDG的2.6至8.3倍,且脑和眶周组织生理性摄取干扰更小,葡萄膜和视网膜内源性色素未引起异常摄取。

要点

  • 18F-PFPN PET检出全部3个眼或眶部黑色素瘤原发灶,18F-FDG PET仅检出2个。
  • 病灶18F-PFPN的SUVmax为18F-FDG的2.6至8.3倍。
  • 18F-PFPN可减少脑和眶周组织生理性摄取干扰,健康对侧眼无异常摄取。

核心结论

  • 与18F-FDG相比,18F-PFPN对眼及眶部黑色素瘤的检出率更高,周围组织干扰小,可能成为鉴别眼及眶部恶性黑色素瘤与良性色素沉着的临床诊断工具。

研究设计与样本

  • 回顾性分析3例病理确诊的眼或眶部黑色素瘤患者(男1例、女2例,年龄41至59岁),每例均行18F-PFPN和18F-FDG PET扫描,以对侧非肿瘤眼为对照。

关键影像表现/征象

  • 18F-PFPN PET检出全部3个原发肿瘤,18F-FDG PET仅检出2个原发肿瘤。
  • 每个病灶内18F-PFPN的SUVmax为18F-FDG的2.6至8.3倍。
  • 18F-FDG PET在脑和眶周组织的生理性摄取限制肿瘤成像,18F-PFPN PET使该干扰最小化。
  • 葡萄膜和视网膜内源性色素未引起18F-PFPN异常浓聚,健康对侧眼未见异常摄取。

临床应用与阅片要点

  • 作者认为18F-PFPN可能成为鉴别眼及眶部恶性黑色素瘤与良性色素沉着的临床诊断工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: 18F-N-(2-(Diethylamino)ethyl)-5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy) picolinamide (18F-PFPN) is a novel positron emission tomography (PET) probe designed to specifically targets melanin. This study aimed to evaluate the diagnostic feasibility of 18F-PFPN in patients with ocular or orbital melanoma.

MATERIALS AND METHODS: Three patients with pathologically confirmed ocular or orbital melanoma (one male, two females; age 41-59 years) were retrospectively reviewed. Each patient underwent comprehensive 18F-PFPN and 18F-fluorodeoxyglucose (18F-FDG) PET scans. The maximum standardized uptake value (SUVmax) of the lesion and the interference caused by background tissue were compared between 18F-PFPN and 18F-FDG PET imaging. In addition, the effect of intrinsic pigments in the uvea and retina on the interpretation of the results was examined. The contralateral non-tumorous eye of each patient served as a control.

RESULTS: All primary tumors (3/3) were detected using 18F-PFPN PET, while only two primary tumors were detected using 18F-FDG PET. Within each lesion, the SUVmax of 18F-PFPN was 2.6 to 8.3 times higher than that of 18F-FDG. Regarding the quality of PET imaging, the physiological uptake of 18F-FDG PET in the brain and periocular tissues limited the imaging of tumors. However, 18F-PFPN PET minimized this interference. Notably, intrinsic pigments in the uvea and retina did not cause abnormal concentrations of 18F-PFPN, as no anomalous uptake of 18F-PFPN was detected in the healthy contralateral eyes.

CONCLUSION: Compared to 18F-FDG, 18F-PFPN demonstrated higher detection rates for ocular and orbital melanomas with minimal interference from surrounding tissues. This suggests that 18F-PFPN could be a promising clinical diagnostic tool for distinguishing malignant melanoma from benign pigmentation in ocular and orbital melanomas.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Wang X, Zhang J, et al. A Novel Melanin-Targeted 18F-PFPN Positron Emission Tomography Imaging for Diagnosing Ocular and Orbital Melanoma. Korean J Radiol. 2024. PMID: 39028010. doi:10.3348/kjr.2024.0243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。